Medtronic Launches VitalFlow ECMO System

Medtronic has launched VitalFlow, a configurable, one-system ECMO (extracorporeal membrane oxygenation) solution.
 
The company acquired VitalFlow from MC3 Cardiopulmonary, a deal that closed in March 2024. The acquisition was the end of an eight-year partnership and distribution agreement, which resulted in introduction of seven new ECMO products in seven years.
 
VitalFlow features a large touch screen that centralizes real-time performance data and configurability. It’s build for long term performance, incorporating Medtronic’s Nautilus ECMO oxygenator design.
 
“The launch of this technology further underscores Medtronic’s unwavering dedication to developing life-restoring medical devices that address both acute and chronic cardiopulmonary clinical needs, and demonstrates our sustained commitment to this vital field,” said Karim Bandali, Ph.D., president of the Medtronics Cardiac Surgery business. “This announcement builds on our recent acquisitions, including a Viant Medical contract manufacturing site and the Penditure Left Atrial Appendage Exclusion System. Clinicians can continue to expect a global cadence of bold and unique innovations, focused on addressing diverse clinician needs while enhancing our ability to meet the needs of all cardiac surgery patients.”
 
The company said the VitalFlow system bridges the gap between bedside care and intra-hospital transport to provide an easier, smarter ECMO experience.
 
“In gathering feedback from hundreds of clinicians with diverse ECMO specialties, we were able to design the VitalFlow system to address the most pressing unmet needs of simplicity, configurability and performance in an ECMO system,” said Bandali. “The simplicity of the VitalFlow system allows multiple users with varying levels of comfort to serve patients confidently and efficiently. It is easily portable from various departments within the hospital setting, with durable and reliable performance.”